[HTML][HTML] How can Cytokine-induced killer cells overcome CAR-T cell limits
E Cappuzzello, E Vigolo, G D'Accardio… - Frontiers in …, 2023 - frontiersin.org
The successful treatment of patients affected by B-cell malignancies with Chimeric Antigen
Receptor (CAR)-T cells represented a breakthrough in the field of adoptive cell therapy …
Receptor (CAR)-T cells represented a breakthrough in the field of adoptive cell therapy …
Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges
Colorectal cancer (CRC) remains a significant global health burden and is the second
leading cause of cancer-related death. Cytokine induced killer (CIK) cell therapy is an …
leading cause of cancer-related death. Cytokine induced killer (CIK) cell therapy is an …
[HTML][HTML] XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with …
QZ Pan, JJ Zhao, L Liu, DS Zhang, LP Wang… - … and Targeted Therapy, 2024 - nature.com
Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard
initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis …
initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis …
Local control and survival after stereotactic radiosurgery for colorectal cancer brain metastases: an international multicenter analysis
O Bin-Alamer, H Abou-Al-Shaar, R Singh… - Journal of …, 2023 - thejns.org
OBJECTIVE The goal of this study was to characterize local tumor control (LC), overall
survival (OS), and safety of stereotactic radiosurgery for colorectal brain metastasis (CRBM) …
survival (OS), and safety of stereotactic radiosurgery for colorectal brain metastasis (CRBM) …
[HTML][HTML] Safety of dendritic cell and cytokine-induced killer (DC-CIK) cell-based immunotherapy in patients with solid tumor: a retrospective study in China
S Wang, Y Song, Q Shi, G Qiao, Y Zhao… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Systematic assessment of adverse side effects of Adoptive T cell therapy, especially cytokine-
induced killer cell and dendric cell treatment Dendritic cells-Cytokine-induced killer (DC …
induced killer cell and dendric cell treatment Dendritic cells-Cytokine-induced killer (DC …
[HTML][HTML] Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique …
Abstract On August 30, 2023, experts from Germany and abroad met to discuss the
successes and challenges of cytokine-induced killer cell (CIK) therapy, that recently …
successes and challenges of cytokine-induced killer cell (CIK) therapy, that recently …
[HTML][HTML] Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review
Y Eralp, U Ates - Vaccines, 2023 - mdpi.com
Malignant neoplasms arising from the gastrointestinal (GI) tract are among the most common
types of cancer with high mortality rates. Despite advances in treatment in a small subgroup …
types of cancer with high mortality rates. Despite advances in treatment in a small subgroup …
[PDF][PDF] ApplicAtion of biomedicAl cell products bAsed on nAturAl Killer cells And cytoKine-induced Killer cells for the treAtment of oncologicAl diseAses
AO Malasheuskaya, NG Antonevich, AY Hancharou - 2024 - practical-oncology.ru
Cellular immunotherapy has become an essential part of modern concepts of oncology
treatment. One of the promising tool of immunotherapy in the treatment of cancer is the use …
treatment. One of the promising tool of immunotherapy in the treatment of cancer is the use …